Schedule 13G ownership disclosure
CARA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 140755208
Event date: 2025-09-30
- Filing-level shares
- 626,190.00
- Percent of class
- 6.7%
- Ronald A. DePinho
Shares: 626,190.00 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001486420-25-000007
- Form type
- SCHEDULE 13G/A
- Filer
- DePinho Ronald A
- CIK
- CIK 1486420
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership